期刊文献+

医院重点监控药品应用分析及干预措施 被引量:5

The Application Analysis and Intervention Measures of Key Monitored Drugs in Hospitals
原文传递
导出
摘要 目的探讨重点监控药品有效管理的措施,以控制药品费用的增长。方法2018年12月制订河源市人民医院重点监控目录及管理制度,应用医院信息系统(HIS)调取2018年(干预前)与2019年(干预后)重点监控药品使用数据,分析医院重点监控药品使用情况、药占比及人均药品费用、使用金额排名前20位的重点监控药品使用变化情况及专项点评情况,评价重点监控药品的管理实践与效果。结果医院实施重点药品监控管理制度后,药占比下降幅度为0.96%,重点监控药品使用金额与干预前比较整体降幅达22.95%,前20位药品总使用金额较干预前降幅达21.56%;通过专项点评,无适应证用药和用法用量不适宜有下降的趋势。结论医院重点监控药品品种的监管措施取得了一定成效,药占比虽下降不明显,重点监控药品使用金额有大幅度下降,在一定程度上促进了临床合理用药。但重点监控药品品种的目录和重点监控处方点评的方法有待进一步完善。 Objective To explore the effective management measures of key monitored drugs in order to control the growth of drug costs.Methods The contents and management institution of key monitored drugs was set in December 2018 in Heyuan People’s Hospital.We used the hospital information system(HIS)to collect data on the use of key monitored drugs in 2018(before the intervention)and 2019(after the intervention),analyzing usage of the key monitored drugs,percentage of drug expenditure,the per capita drug cost,the top 20 key monitored drugs and the special prescription comment,to evaluate the management practice and effect on key monitored drugs.Results After the implementation of the management system of key monitored drugs,the drop in percentage of drug expenditure was 0.96%,the drop in total amount of key monitored drugs was 22.95%compared with that before the intervention,and the drop in total amount of the top 20 key monitored drugs was 21.56%.Through special reviews,there was a trend of decrease in the unindicated drug use and inappropriate dosage.Conclusion The supervision measures of the key monitoring drugs in our hospital have achieved certain effects,although the proportion of drugs decreased unconspicuous.The total amount of key monitored drugs decreased by a large margin,which promoted the drugs rational use in clinics in some degree.However,the contents and the method of commenting on prescription of the key monitored drugs needs to be further improved.
作者 李湘 黄双英 张婷婷 曾燕聪 LI Xiang;HUANG Shuang-Ying;ZHANG Ting-Ting;ZENG Yan-Cong(Department of Pharmacy of Heyuan People's Hospital of Guangdong Province,Heyuan 517000,China)
出处 《中国药物经济学》 2020年第8期66-70,共5页 China Journal of Pharmaceutical Economics
关键词 专项点评 重点监控药品 药占比 合理用药 Special comment Key monitored drugs Percentage of drug expenditure Reasonable application for drugs
  • 相关文献

参考文献14

二级参考文献129

  • 1吴永佩,颜青.试论医院药事管理学的发展(一)[J].中国药房,2004,15(7):406-408. 被引量:30
  • 2吴永佩,颜青,李喜西.加强教育与干预 促进临床合理用药[J].中国医院,2004,8(8):10-12. 被引量:57
  • 3赖威,卢实春,赵纪春,严律南,李波,文天夫,王文涛,马玉奎,刘隽,戴军,赵冀,周静,潘传芳,邓承琪,罗燕,彭玉兰,马步云.前列地尔在肝移植中使用的临床意义评价[J].消化外科,2004,3(5):308-312. 被引量:5
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5北京市卫生局.《北京市医疗机构处方专项点评指南(试行)》[S].2010.
  • 6国家卫生和计划生育委员会.公立医院改革试点工作简报:第180期[EB/OL](.2011-12-15)[2015-07-01].http://www.nhfpc.gov.cn/yzygj/s10006/201112/9afbf1647f074f6497c3579fbf1b8145.shtml.
  • 7OECD.Health at a glance 2013[EB/OL](.2013-12-21)[2015-07-01].http://dx.doi.org/10.1787/health_glance-2013-67-en.
  • 8OECD.Health at a glance:Europe 2014[EB/OL].(2014-12-03)[2015-07-01].http://dx.doi.org/10.1787/health_glance_eur-2014-54-en.
  • 9卫计委.卫生部令[2007]53号处方管理办法[S].2007.
  • 10卫计委.卫医管发[2010]28号医院处方点评管理规范:试行[S].2010.

共引文献266

同被引文献56

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部